C
HBIO icon

Certuity’s Harvard Bioscience HBIO Stock Holding History

Certuity’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,368
Closed -$9.15K – 677
2025
Q4 		$9.15K Hold
1,368
– – ﹤0.01% 586
2025
Q3 		$6K Sell
1,368
-103
-7% -$489 ﹤0.01% 559
2025
Q2 		$6.53K Hold
1,471
– – ﹤0.01% 426
2025
Q1 		$8.33K Hold
1,471
– – ﹤0.01% 404
2024
Q4 		$31K Hold
1,471
– – ﹤0.01% 375
2024
Q3 		$39.6K Buy
1,471
+1
+0.1% +$29 ﹤0.01% 350
2024
Q2 		$41.9K Buy
1,470
+32
+2% +$1.12K ﹤0.01% 350
2024
Q1 		$61K Hold
1,438
– – 0.01% 318
2023
Q4 		$76.9K Hold
1,438
– – 0.01% 338
2023
Q3 		$61.8K Buy
1,438
+4
+0.3% +$185 0.01% 258
2023
Q2 		$78.7K Hold
1,434
– – 0.01% 258
2023
Q1 		$60.2K Hold
1,434
– – 0.01% 218
2022
Q4 		$39.7K Hold
1,434
– – 0.01% 210
2022
Q3 		$37K Sell
1,434
-2,496
-64% -$82.6K 0.01% 191
2022
Q2 		$141K Buy
3,930
+100
+3% +$4.51K 0.04% 208
2022
Q1 		$238K Hold
3,830
– – 0.05% 255
2021
Q4 		$270K Hold
3,830
– – 0.06% 235
2021
Q3 		$267K Hold
3,830
– – 0.05% 304
2021
Q2 		$319K Buy
+3,830
New +$271K 0.07% 224

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $118M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Certuity's HBIO Position: Q1 2026 in Review

Certuity sold out of Harvard Bioscience (HBIO) in Q1 2026, closing a stake of 1,368 shares — an estimated $9.15K sold.

Certuity first reported a position in HBIO in Q2 2021 and held it in 19 quarters. The position peaked at $319K in Q2 2021. 37 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.

  • Certuity reported no remaining Harvard Bioscience position as of Q1 2026 after selling out during the quarter.
  • Certuity sold 1,368 Harvard Bioscience shares in Q1 2026, an estimated $9.15K.
  • Certuity first reported a position in Harvard Bioscience in Q2 2021 and held it in 19 quarters.
  • Certuity's Harvard Bioscience position peaked at $319K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.

Based on Certuity's 13F filing for Q1 2026, filed 11 May 2026.